KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Inventory (2016 - 2025)

Historic Inventory for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $438.0 million.

  • West Pharmaceutical Services' Inventory rose 917.25% to $438.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $438.0 million, marking a year-over-year increase of 917.25%. This contributed to the annual value of $377.0 million for FY2024, which is 1327.35% down from last year.
  • West Pharmaceutical Services' Inventory amounted to $438.0 million in Q3 2025, which was up 917.25% from $421.1 million recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Inventory registered a high of $449.4 million during Q2 2023, and its lowest value of $310.2 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory was $414.8 million (2022), whereas its average is $404.3 million.
  • Per our database at Business Quant, West Pharmaceutical Services' Inventory surged by 3426.82% in 2022 and then tumbled by 1327.35% in 2024.
  • West Pharmaceutical Services' Inventory (Quarter) stood at $378.4 million in 2021, then grew by 9.62% to $414.8 million in 2022, then rose by 4.8% to $434.7 million in 2023, then decreased by 13.27% to $377.0 million in 2024, then increased by 16.18% to $438.0 million in 2025.
  • Its Inventory stands at $438.0 million for Q3 2025, versus $421.1 million for Q2 2025 and $388.7 million for Q1 2025.